Topical mycophenolate mofetil in the treatment of vitiligo: a pilot study
Background: Vitiligo is a multifactorial disease that is characterized by circumscribed depigmented macules and patches. Autoimmune reactions may play an important role in the pathogenesis of the disease. Mycophenolate mofetil is a drug that inhibits DNA synthesis in lymphocytes and has been used i...
Guardado en:
Autores principales: | Farhad Handjani, Shahin Aghaei, Iman Moezzi, Nasrin Saki |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Mattioli1885
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c346a1a33b2b476299bc64e2f48e302e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Mycophenolate mofetil versus Rapamycin in Han: SPRD rats with Polycystic Kidney Disease
por: ZHANG,TONG, et al.
Publicado: (2009) -
Atrofia vellositaria duodenal inducida por micofenolato mofetil: Caso clínico
por: TAPIA E,OSCAR, et al.
Publicado: (2010) -
Solid Lipid Nanoparticles of Mycophenolate Mofetil: An Attempt to Control the Release of an Immunosuppressant
por: Iqbal A, et al.
Publicado: (2020) -
Utility of Blue Light in Dermoscopy for Diagnosing Stable Lesions in Vitiligo
por: Balakrishnan Nirmal
Publicado: (2021) -
Vitiligo Extent Tensity Index (VETI) score: a new definition, assessment and treatment evaluation criteria in vitiligo
por: Amir Feily
Publicado: (2019)